ECOG-ACRIN Central Biorepository and Pathology Facility
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has a Central Biorepository and Pathology Facility (EA-CBPF) as part of its laboratory network. This facility provides and coordinates services to collect, process, store, catalog, ensure quality control, and distribute biospecimens with annotated clinical and molecular data. These biospecimens are obtained from patients enrolled in clinical trials across ECOG-ACRIN’s three scientific programs: Therapeutic Studies, Biomarker Sciences, and Cancer Control and Outcomes.
Leadership
The EA-CBPF is located at The University of Texas MD Anderson Cancer Center in Houston. Listed below are the members of the leadership team, contact information, and a brief history of the facility.
Clinical Trials Director
Program Director
Clinical Hematopathologist
Laboratory Informatics Director
Russell Broaddus, MD, PhD
Michael T. Balco, CT (ASCP)
Pei Lin, MD
Mark Routbort, MD, PhD
Background
In 2014, the ECOG-ACRIN Cancer Research Group made important modifications to its biorepositories and pathology capabilities, consolidating the majority of its banking activities into the ECOG-ACRIN Central Biorepository and Pathology Facility (EA-CBPF) at The University of Texas MD Anderson Cancer Center in Houston, TX. The new location opened on November 3, 2014. For more information, read a series of articles published in the November 2014 ECOG-ACRIN Newsletter.
Contact Information
ECOG-ACRIN Central Biorepository and Pathology Facility
MD Anderson Cancer Center
Department of Pathology, Unit 085
Tissue Qualification Laboratory for ECOG-ACRIN, Room G1.3598
1515 Holcombe Blvd
Houston, TX 77030
Phone: 844.744.2420 (toll-free callers)
Phone: 713.745.4440 (local or international callers)
Fax: 713.563.6506
